NCT02555267
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Chonbuk National University Hospital Jeonju, South Korea
Clinical trial condition
Lymphoma, Large B-Cell, Diffuse
Explore clinical trials studying Lymphoma, Large B-Cell, Diffuse. Study availability and eligibility vary by location and protocol.
59 public trials
6 recruiting studies
Lymphoma, Large B-Cell, Diffuse trial results
NCT03211702
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Chonnam National University Hwasun Hospital Hwasun, South Korea
- Chonbuk National University Hospital Jeonju, South Korea
NCT03049449
- Conditions
- Enteropathy-Associated T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
NCT00849147
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +23 more
- Locations
-
- City of Hope National Medical Center Duarte, California, United States
- University of California San Diego Medical Center La Jolla, California, United States
- University of Florida College of Medicine (Shands) Gainesville, Florida, United States
- Bone Marrow Transplant Group of Georgia, Northside Hospital Atlanta, Georgia, United States
NCT00864227
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +23 more
- Locations
-
- City of Hope National Medical Center Duarte, California, United States
- University of Florida College of Medicine, Shands Gainesville, Florida, United States
- H. Lee Moffitt Cancer Center Tampa, Florida, United States
- University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
NCT03536039
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Ospedale San Raffaele Milan, Italy
NCT03682796
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
- Locations
-
- Banner MD Anderson Gilbert, Arizona, United States
- Roswell Park Comprehensive Cancer Center Buffalo, New York, United States
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
- Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States
NCT02883517
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
- Locations
-
- University Hospital of Bordeaux - Hospital Saint André Bordeaux, France
Completed
Translational Study of Molecular Classification of Relapsed/Refractory Diffuse Large B-cell Lymphoma
NCT05318391
- Conditions
- Gene Expression Profiling, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Yian Zhang Shanghai, Shanghai Municipality, China
Completed
Brentuximab Vedotin and Lenalidomide for Relapsed or Refractory Diffuse Large B-cell Lymphoma
NCT02086604
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Washington University School of Medicine St Louis, Missouri, United States
- Ohio State University, James Cancer Hospital Columbus, Ohio, United States